ABSTRACT-The essential moieties in p-phenylene-polymethylene bis-ammonium (PMBA) deriva tives, C6H4[X(CH2)nN+R3]2, on the potentiating effects by 8-eudesmol, a main component of Atracty lodes lancea, of their neuromuscular blockades were investigated in isolated phrenic nerve-diaphragm muscle preparations of normal and alloxan-diabetic mice. PMBA derivatives were separated into the following three groups based on the patterns of the potentiating effects: group I: PMBA-23 (n = 6, R = Me) and PMBA-24 (n = 6 , R = Et); group II: PMBA-1 (n = 4, R = Me), PMBA-21 (n = 4, R = Et) and PMBA-2 (X = 0, n = 3, R = Me); and group III: PMBA-31 (X = S, n = 3, R = Me), PMBA-3 (X = CO, n = 3, R = Me) and PMBA-4 (X = CHOH, n = 3, R = Me). The pretreatment with 80 ,uM ,8-eudesmol for 60 min did not affect group I-induced neuromuscular blocking action, and it potentiated group II and group III-induced ones. The potentiating effect of /3-eudesmol on group III was greater in diabetic muscles than in normal ones and that on group II was to the same extent in both muscles. These results suggest that the four-methylene length of the side chains in normal muscles and the hydrophilic moieties adjacent to a phenylene ring in diabetic muscles are related to the potentiating effect by,8-eudesmol on PMBA derivatives.
The change of sensitivity to various neuromuscular blockers in the neuromuscular transmission of diabetic animals has been demonstrated. Succinylcholine (SuCh), a depolarizing blocker, inhibits the neuro muscular transmission with a higher sensitivity in dia betic skeletal muscles than in normal ones (1 3) . Another depolarizing blocker, decamethonium (CIO), inhibits it with the same sensitivity in both muscles (2, 4) or rather with a lower sensitivity in diabetic motor endplates (3) . We have previously reported that ,8 eudesmol, a compound from Atractylodes lancea rhi zoma, potentiates the neuromuscular blocking effects of SuCh and C10 but not that of the competitive blocker pancuronium and that the potentiating effects are great er in diabetic muscles than in normal ones (2) . Single channel recordings indicate that ,8-eudesmol blocks the nicotinic acetylcholine-receptor channels in both open and closed conformations in normal skeletal muscle cells (5) . To clarify the essential chemical structure in SuCh blockade potentiated by ,8-eudesmol in diabetic muscles, we synthesized unhydrolyzable compounds, p phenylene-polymethylene bis-ammonium (PMBA) de rivatives. Thus, the present aim is to study the structure-activity relationship of PMBA derivatives pro ducing the potentiating effect by 8-eudesmol in normal and diabetic skeletal muscles.
MATERIALS AND METHODS
Male mice (ddY strain, 4 weeks) were injected with alloxan monohydrate (85 mg/kg, Nacalai Tesque) into the tail vein and were used at 4 5 weeks after the in jection. The phrenic nerve-diaphragm muscles of nor mal (28 36 g) and alloxan-diabetic (24 39 g, feeding blood glucose level: 360 600 mg/dl) mice were iso lated. The isometric twitch tensions were obtained under 1 g loading tension, by stimulating the phrenic nerve and the muscle, alternately (0.2 Hz, 1 msec dura tion, supramaximal voltage), through a bipolar plati num electrode. Each PMBA derivative was applied cumulatively at 2-min intervals after pretreatment with The synthesis of these PMBA derivatives will be described elsewhere.
The statistical significance was analyzed by Student's t-test for unpaired observations at P = 0.05 or 0.01. Table 1 . Potentiating effect of 8-eudesmol on the neuromuscular blocking action of p-phenylene-polymethylene bis-ammonium compounds, p-C6H4[(CH2)"N+R312, in normal and alloxan-dia betic mice
RESULTS
All PMBA compounds used in this study blocked the nerve-evoked twitch response, without affecting the contraction evoked by stimulation of the muscle. The blocking effects were readily reversed on washout. They were not reversed by 15 ,uM neostigmine, a cho linesterase inhibitor, which fully reversed d-tubocur arine (6.5 u M) -induced complete inhibition of indirectly stimulated twitch tension (data not shown).
Blocking effects of PMBA-1 and PMBA-23, with or without ~8-eudesmol PMBA-1, a bis-trimethylammonium (BTMA) deriva tive with n = 4, and PMBA-23, a BTMA derivative with n = 6, inhibited the nerve-evoked twitch tension in a concentration-dependent manner (Fig. 1, A and  B) . The blocking effects of PMBA-1 and PMBA-23 were significantly more potent in diabetic muscles than in normal ones. Pretreatment with 80 uM ,8-eudesmol for 60 min potentiated the blocking effect of PMBA-1 to 1.9-fold in normal muscles and to 1.7-fold in diabetic ones. This concentration of ,8-eudesmol by itself did not affect twitch tensions. Pretreatment with /3-eudes mol did not affect the blocking effect of PMBA-23 (Table 1) .
Blocking effects of PMBA-21 and PMBA-24, with or without , 8-eudesmol In both normal and diabetic skeletal muscles, the neuromuscular junction was similarly blocked by PMBA-21, a bis-triethylammonium (BTEA) derivative with n = 4, and PMBA-24 (a BTEA derivative with n = 6) , with no apparent differences in effect (Fig. 2, A and B). Pretreatment with 8-eudesmol potentiated the blocking effect of PMBA-21, but not that of PMBA-24, to 1.7-fold in both muscles (Table 1) .
Blocking effects of PMBA-2, PMBA-31, PMBA-3 and PMBA-4, and its potentiation by fi-eudesmol
The blocking effects of PMBA-2 (a BTMA derivative with X = 0), PMBA-31 (X = S), PMBA-3 (X = CO) and PMBA-4 (X = CHOH) (Fig. 3: A, B , C and D, respectively) were potentiated by 8-eudesmol, to 2.6-, 2.8-, 2.0 and 5.6-fold in normal muscles and to 2.6-, 6.4-, 7.5 and 8.5-fold in diabetic ones, respectively. The extents of potentiation for PMBA-2 were not dif PMBA-4 were greater in diabetic muscles than in nor mal ones, although PMBA-31 or PMBA-3 by itself ex hibited weaker effects in diabetic muscles than in nor mal ones (Table 2 ). 
DISCUSSION
SuCh has been previously shown to inhibit neuro muscular transmission with a higher sensitivity in dia betic state (1-3), and to further inhibit it to a greater extent in the presence of f3-eudesmol (2). To clarify the mechanism of hypersensitivity to SuCh potentiated by ,8-eudesmol in the diabetic state, we synthesized PMBA compounds instead of SuCh, which is promptly hydro lyzed by pseudocholinesterase in vivo. The present study demonstrated that unhydrolyzable PMBA derivatives had various sensitivities to neuromuscular blockade in diabetic skeletal muscles. Therefore, the modification of neuromuscular transmission may be independent of the change of cholinesterase activity in the diabetic state (4, 6) . We think rather that it results from an al teration in the post-junctional acetylcholine receptors, because PMBA derivatives-induced neuromuscular blockades in the diabetic state were greatly affected by f3-eudesmol, which is a nicotinic acetylcholine receptor channel blocker (5) .
BTMA derivatives, but not BTEA derivatives, de polarize the endplate membrane of mouse diaphragm muscles (7), like various series of alkyltrialkylammo nium compounds (8) (9) (10) . However, the potentiating pattern by f3-eudesmol was not different between PMBA-1 and PMBA-21 and between PMBA-23 and PMBA-24. These results suggest that PMBA-induced membrane depolarizations are not necessarily related to the potentiating effect by ,8-eudesmol, but the proper distance between two nitrogen atoms in the bis-ammo nium groups of PMBA derivatives is important for pro ducing the potentiating effect by 8-eudesmol.
The potentiating patterns by ,8-eudesmol on the neuromuscular blocking action of the PMBA deriva tives in normal and alloxan-diabetic skeletal muscles can be used to classify these compounds into 3 groups: In group I containing PMBA-23 and -24, the blocking effects were not affected by ,8-eudesmol; In group II containing PMBA-1, -21 and -2, the effects were po tentiated by 8-eudesmol to the same extent in normal and diabetic muscles; and in group III containing PMBA-31, -3 and -4, the effects were markedly potenti ated, and the extent was greater in diabetic muscles than in normal ones. According to our previous study on the potentiating effects by fl-eudesmol (2), pancuro nium, a competitive neuromuscular blocker, belongs to group I, and SuCh and CIO, depolarizing blockers, be long to group III (Table 1) . On the other hand, the PMBA derivatives used in this study were not competi tive blockers because their blocking effects were not re versed by neostigmine. This classification into 3 groups of PMBA derivatives indicated structural features of PMBA derivatives reflecting the susceptibility to the potentiating effect of 8-eudesmol. The compounds be longing to group I have longer methylene chains, and the compounds belonging to group III have hydrophilic moieties adjacent to the phenylene ring. These results suggest that the distance, comparable to a ten methylene length, between the two nitrogen atoms in the bis-ammonium groups of PMBA derivatives SuCh and C10 is prerequisite for the potentiating effect by / eudesmol and that the hydrophilic moieties adjacent to the phenylene ring in PMBA derivatives are important for augmenting the potentiating effect by ,8-eudesmol in diabetic muscles.
In conclusion, this study on the structure-activity re lationship of PMBA derivatives on their neuromuscular blockades suggests that the four-methylene length of the side chains in normal muscles and the hydrophilic moieties adjacent to the phenylene ring in diabetic mus cles are related to the potentiating effect of ,8-eudesmol on PMBA derivatives.
